Terry Rich buys 808,204 share of his company at a value of $1,212,306
|
COMPANY INFORMATION
|
||
|
SRGA by TradingView
|
Company Info:
Surgalign (formerly RTI Surgical) remains a global leader with our innovative spine solutions. Our comprehensive line of spine products and differentiated specialty products are backed by clinical research and are reshaping the standard of care in spine. We are deeply committed to new product innovation and delivering spine solutions designed in partnership with surgeons and experts to meet the diverse needs of spine patients globally.
Over the past five years, we have tripled the size of our business to stand among the leading global spine companies. As we continue to grow, we are relentlessly focused on serving as the partner of choice for independent surgeons and advancing the innovation, quality and outcomes patients expect and deserve.
With double-digit new product introductions over each of the next two years, we will pioneer the next phase in spine technology innovation in 2020 and beyond enabling us to treat more spine patients than ever before.
Over the past five years, we have tripled the size of our business to stand among the leading global spine companies. As we continue to grow, we are relentlessly focused on serving as the partner of choice for independent surgeons and advancing the innovation, quality and outcomes patients expect and deserve.
With double-digit new product introductions over each of the next two years, we will pioneer the next phase in spine technology innovation in 2020 and beyond enabling us to treat more spine patients than ever before.
|
LATEST INSIDER ACTIVITY
|
||
|
INSIDER:
Terry Rich
SHARES BOUGHT:
808,204
PURCHASE DATE:
2/01/2021 |
TITLE:
CEO
% INCREASE:
265%
FILE DATE:
2/02/2021
|
|
|
INSIDER PURCHASE PRICE
$1.50
|
||
Insider Notes:
Stolper Mark Dir P - Purchase $1.50 +$25,001
Simpson Stuart F. Dir P - Purchase $1.50 +$500,000
Durall William Scott Chief Commercial Officer +$500,000
Lewicki Pawel Dir P - Purchase $1.50 +$3,000,000
Lightcap Jeffrey C Dir P - Purchase $1.50 +$250,001
Simpson Stuart F. Dir P - Purchase $1.50 +$500,000
Durall William Scott Chief Commercial Officer +$500,000
Lewicki Pawel Dir P - Purchase $1.50 +$3,000,000
Lightcap Jeffrey C Dir P - Purchase $1.50 +$250,001
|
ANALYST RECOMMENDATION
|
||
|
TARGET PRICE:
5.40 TARGET GAIN:
120%+ |
AVERAGE RATING:
BUY ANALYST COVERING:
5 |
|
| IMPORTANT DISCLOSURE | ||
|
TECHNICAL ANALYSIS
|
||
|
|
|
|